Contraceptive is one of 166 small molecule programs targeting Contraception. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
392 competitors in Obesity
Contraceptive
Actemra
Avapro
Calciferol
Adenocard
Activella
Ultiva
Oxycontin
Spiriva
Flagyl
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources